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Abstract
More American women are taking up smoking than men and fewer are quitting; if current trends continue,
rates for women will surpass those for men by the mid-1990's. But ironically, much of what is known about the
biobehavioural aspects of smoking is based on research using male subjects. TJie present paper reviews evidence
suggesting that: (1) women may differ from men with regard to nicotine intake and/or effects; (2) nicotine
intake and effects may be influenced by menstrual cycle phase; (3) oral contraceptive use and estrogen
replacement therapy may affect intake and effects of nicotine; (4) the effects of chronic nicotine use on female
reproductive endocrinology may have implications for the reinforcement of smoking; and (5) pharmacological
agents used to treat smoking may have different effects in women than in men. Guidelines and suggestions are
presented by future biobehavioural research in women, including standardization of assessment procedures,
attention to the use of appropriate controls, and use of pharmacological probes.
Introduction
In the wake of Surgeon General Luther Terry's
landmark report (USPHS, 1964) documenting the
negative health effects of cigarette smoking, the
prevalence in American men declined much more
steeply (from 50.2% in 1965 to 31.7% in 1987) than
in women (from 31.9% to 26.8%; USDHHS, 1989).
If current trends continue, smoking rates for women
will surpass those for men by the mid-1990's
(USDHHS, 1989). Initiation rates have dropped
much faster among males than among females
(USDHHS, 1989). Women quit with greater diffi-
culty (or perhaps are treated less successsfuUy,
using methods less appropriate to them; e.g. Blake et
al., 1989; USDHHS, 1980) and are more likely to
relapse than their male counterparts (Gritz, 1980).
As major users of the health care system, women
have probably been adequately studied in treatment
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trials (e.g. Hooper, 1990). But ironically, much of
the basic behavioural and biological research that
underlies the development of these treatment strat-
egies has been carried out in males. Perhaps there
will turn out to be more similarities than differences
between men and women with respect to smoking
patterns and effects of nicotine; but such a conclu-
sion must be demonstrated, not assumed. If we wish
to know about smoking in women, we must study
women directly. The remainder of this paper will
focus on questions that will need to be addressed,
reviewing briefly what is known and discussing the
kind of research required to fill the gaps in our
knowledge.
Women may differ from men with regard to
nicotine intake and/or effects
A certain amount of evidence has been amassed for
sexual dimorphism in the effects of nicotine (Grun-
berg et al, in press). Clearance of nicotine corrected
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for body weight has been found to be significantly
higher in men than in women (Benowitz & Jacob,
1984); it has also been reported that women smoke
fewer cigarettes than men but achieve comparable
blood nicotine levels. Both these findings suggest
that the effects of a given dose of nicotine may be
more pronounced, if not qualitatively different, in
women than in men. In keeping with this inference,
Gninberg et al. (1986) have found that female rats
are more sensitive than males to the effects of
nicotine on body weight and feeding during and
after drug administration. Other investigators have
found male-female differences in motives for smok-
ing (Russell et al., 1974) and in the kind of
situations in which smoking is likely to occur (e.g.
Ikard & Tomkins, 1973). Although smoking rates
have been linked to environmental stressors in both
genders (e.g. Linsky et al., 1986), higher rates of
negative-affect smoking in women may suggest that
they respond differentially to stress or have fewer
available instrumental responses for coping with
stress. Alternatively, it has been proposed that
nicotine is excreted faster when urinary pH is low,
as occurs under stress (Schachter, 1978), and that
changes in urinary pH produce greater excretion of
nicotine in women than in men (e.g. Beckett et al.,
1971). And although the literature is equivocal,
evidence has been adduced to support the hypothe-
sis that women, who have been shown in research on
cognitive styles to be more responsive to external
stimuli, may find the distraction-filtering effects of
nicotine more useful than do men (see Biener,
1987). Interestingly, women smokers trying to quit
are more likely to describe themselves as 'addicted'
than are their male counterparts (Eiser & Van Der
Pligt, 1986).
Nicotine intake and smoking behaviour may be
affected by menstrual cycle phase
Investigation is needed of the possibility that the
more than 200 physical, psychological, and behav-
ioural changes associated with the ovarian cycle
(Magos, 1988) have a systematic impact upon
smoking behaviour in some or all regularly cycling
women smokers. When we ask whether what is
known about male subjects can be extrapolated to
women, we must add 'to women when?'. A woman
studied at one point in her menstrual cycle may
perform differently at another, for reasons unre-
lated, or related in some complicated way, to the
experimental manipulation.
The idea that drug use may fluctuate over the
menstrual cycle, perhaps peaking at the premen-
strual phase, has considerable face validity; but
despite attempts to demonstrate such a phenomenon
for several psychoactive substances, including caffe-
ine, alcohol and marijuana, the only compelling
evidence advanced to date has been in the presence
of premenstrual syndrome (PMS). On the other
hand, other appetitive responses—notably craving
for food and food intake—have been convincingly
shown to increase during the premenstruum.
Though the literature on smoking across the
menstrual cycle is scanty, there is in fact a small
amount of direct evidence to suggest that smoking
behaviour and withdrawal symptomatology do
change in response to menstrual phase. Based on
automated measures of smoking topography, Stein-
berg & Cherek (1989) found that most subjects
smoked more during menses than during the pre-
menstrual phase or any other time. Mello et al
(1987), looking at cigarette smoking and alcohol
self-administration in women, found that nearly
three-quarters increased smoking, as measured by
inter-cigarette interval, during the premenstruum.
All women reported increased psychological dis-
comfort during the premenstruum, but reports of
physical discomfort were more marked in women
who smoked less during the premenstruum. O'Hara
et al. (1989), in a study of premenopausal smokers
enrolled in a smoking cessation clinic, found that
subjects who quit during the luteal phase showed
significantly higher ratings of withdrawal symptoms.
Highly significant correlations were found between
withdrawal scores and symptoms of menstrual
distress.
Because of design limitations and inconsistent
definitions of phase, these studies raise as many
questions as they answer. Although two of the three
tend to suggest more smoking and more desire to
smoke during the latter part of the cycle, it is
difficult to specify precisely the phase associated
with increased smoking or to relate these studies to
one another. The third study, by contrast, showed
the highest smoking level during the menses;
because days 1-2 were not distinguished from the
remainder of the menses, it is not clear how much
smoking in response to dysmenorrhea (see below)
might have contributed to this effect. The absence
of biochemical verification of menstrual phase or
measures of plasma nicotine may also bear on the
findings. Thus, inferences of greater self-adminis-
tration either during menses or the premenstruum
remain unconfirmed.
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Effects of nicotine may vary across the
menstrual cycle
There is also a certain amount of inferential
support, based on the known effects of smoking, for
the hypothesis that smoking varies across (and in
response to) menstrual phase. Smoking has fre-
quently been demonstrated to serve as a pharmacol-
ogical 'coping response' that can cause small but
reliable alterations in performance or affect (Pom-
erleau & Pomerleau, 1984). Behaviours and subjec-
tive states influenced by smoking or nicotine
administration include improvement of various
kinds of performance, such as tasks requiring
vigilance or motor skills; decreased preference for
and consumption of sweet-tasting food; decreased
overall food consumption in female (but not male)
rats; alleviation of anxiety; and antinociception (see
USDHHS, 1988). Glassman et al. (1988) reported
that smokers are more likely to have a history of
clinical depression and suggested that some may
smoke as a way of self-medicating.
Interestingly, the behavioral and subjective states
affected by smoking have been demonstrated to
fluctuate systematically over the course of the
menstrual cycle. Hampson & Kimura (1988), for
example, have shown that during the midluteal phase,
women tend to perform better on motor coordination
tasks and worse on perceptual-spatial tests than do the
same women during menses. Thus, women may
smoke differentially in response to different types of
challenge in an attempt to compensate for hormo-
nally-induced performance deficits.
Numerous investigators have reported greater
food intake, body weight, and craving for food,
sweet-tasting food, or chocolate in the luteal phase
than in the foUicular phase (e.g. Bowen & Grunberg,
1990; Dalvit, 1981). Since nicotine causes shifts in
preference for and consumption of sweet-tasting
foods, it is plausible that nicotine's well-docu-
mented anorectic and weight-depressing effects may
increase in reinforcing value at key points in the
menstrual cycle, especially in weight-conscious
women.
Negative affect has been shown to increase
premenstrually, especially in women who experi-
ence mood fluctuations over the menstrual cycle.
Schechter et al. (1989), for example, recently
reported significant increases in ratings of negative
mood and 'less sociable' during the late-luteal phase
as compared with four other endocrinologically-
defined segments of the cycle. It is not unreasonable
to suppose that smoking is likely to increase at times
when anxiety or depressive states are most severe.
Finally, some though not all investigators (see
Veith et al., 1984) have reported changes in pain
sensitivity and tolerance over the menstrual cycle,
generally reaching a nadir during the luteal or late-
luteal phase (Hapidou & De Catanzaro, 1988; Rao et
al., 1987). Furthermore, Andersch & Milsom
(1982) found that compared with non-smokers,
females who smoke have significantly less severe
dysmenorrhea, suggesting the possibility that smok-
ing may relieve menstrual cramps. Thus, smokers
suffering from dysmenorrhea may seek relief by
smoking more during the early menses.
Though mechanisms whereby smoking might
interact with hormonal fluctuations remain to be
elucidated, nicotine administration has been shown
in rats and humans to stimulate the release of
dopamine, norepinephrine, beta-endorphin, cortisol,
ACTH, growth hormone, vasopressin, and other
neuroregulatory substances (see Pomerleau & Rose-
crans, 1989), many of which are involved in the
regulation of affect or psychomotor performance.
Since these substances are also influenced by
menstrual cyclicity (Speroff et al., 1989), it is
possible that smoking can be 'used' to compensate
for adverse affective, cognitive, or physiological
changes associated with different phases of the
menstrual cycle. Alternatively, or additionally, al-
terations in the distribution, metabolism, and excre-
tion of nicotine could result in decreased blood
levels of nicotine at predictable times during the
cycle, thereby leading to compensatory smoking
(Steinberg & Cherek, 1989).
Oral contraceptive use and estrogen replace-
ment therapy may affect intake and effects of
nicotine
Given the large numbers of women smokers who
use oral contraceptives, and the negative health
implications of combining the two practices (Gritz,
1980), it is important to determine the effects of
exogenous steroids on smoking behavior and the
effects of nicotine.
The effects of chronic nicotine use on female
reproductive endocrinology may have implica-
tions for the reinforcement of smoking
Smoking appears to have a direct effect upon the
menstrual cycle. The prevalence of menstrual
irregularities is higher in smokers than in non-
smokers (e.g. Brown et al., 1988). Moreover,
current smokers have been reported to reach
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menopause an average of 1.74 years earlier than
non-smokers (McKinlay et al., 1985), and to have
an increased incidence of osteoporosis (Baron,
1984), both of which are associated with a state of
relative estrogen deficiency (Michnovicz et al.,
1986). Possibly the antiestrogenic effects of nicotine
produce changes in likelihood of ovulation, of
menstrual cramps, and of premenstrual symptoma-
tology, which in turn could affect smoking behavior.
Pharmacological agents used to treat smoking
may affect women differentially
A number of drugs (e.g. antidepressants, antipsy-
chotics) are known or suspected to have gender-
specific effects or side-effects (see Hamilton, 1986).
Several drugs, including nicotine itself, clonidine,
fluoxetine, and mecamylamine, have been te,sted- as
possible aids in smoking cessation; these drugs may
likewise have differential effects in women. Glass-
man et al. (1988), for example, found clonidine
promoted smoking cessation in women but not men;
Killen et al. (1990), on the other hand, found
nicotine polacrilex to be more effective in men than
in women. Gender-specific concerns or needs may
also have an indirect influence on drug efficacy.
Fluoxetine, a drug with appetite-suppressing ef-
fects, for example, may be more helpful to women,
who exhibit greater concern than men about the
weight-gain that generally accompanies nicotine
discontinuation (Sorensen & Pechacek, 1987).
What is needed?
The need to take into account menstrual status and
phase, risk of pregnancy, and use of exogenous
steroid hormones, at least until we rule out the
possible contributing effects of these factors, clearly
adds an extra layer of complexity to the use of
women as research subjects. On the other hand,
these natural or artificial hormonal manipulations
also represent research opportunities, with the
potential for serving as independent variables that
could increase our understanding of the functional
relationships among hormones, behavior, and the
reinforcement of smoking.
In any event, if we are to accumulate information
efficiently, there are a number of considerations that
need to be addressed. For example, it would be
desirable to standardize definitions and criteria for
verification of menstrual status, questionnaires used
to assess subjective responses and mood cycling,
measures of nicotine dependence, etc. so that
studies will be mutually interpretable. Careful
thought must be given to the appropriate control for
a given study, be it time-yoked male controls, pre-
versus post-menopausal women, women with and
without premenstrual symptomatology, repeated
measures using women at different menstrual
phases, smokers versus non-smokers, highly depen-
dent versus less dependent smokers, etc. In addi-
tion, we need imaginative new approaches to
experimental manipulation; possible strategies in-
clude controlled administration of steroid hor-
mones, use of hormone blockers, and other pharma-
cological manipulations of neuroregulatory activity
—e.g. cholinergic, adrenergic, and opioid agonists
and antagonists. Finally, it is important to study
women not just in contrast to men, or in the hopes of
generalizing from men to women, but as a popula-
tion subject to a range of individual differences that
need to be studied in and of themselves.
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